Likelihood of Approval and Phase Transition Success Rate Model - Peptides to 2 Agonize GLP-1 and GCGR for Diabetes and Obesity
Likelihood of Approval and Phase Transition Success Rate Model - Peptides 1 to Agonize GLP-1 and GCGR for Diabetes and Obesity
Obesity (Metabolic Disorder) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update